Brentjens Highlights BCMA, Next Steps With CAR T-Cell Therapy – OncLive
OncLive |
Brentjens Highlights BCMA, Next Steps With CAR T-Cell Therapy
OncLive OncLive: Can you discuss other targets being investigated in addition to CD19 for CAR T-cell therapy? Brentjens: There has been a significant amount of success targeting CD19 on B-cell cancers. In fact, there are 2 drugs that are now commercially … |
